165 related articles for article (PubMed ID: 30152250)
1. Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.
Giorgi-Pierfranceschi M; Artom N; Di Pasquale G; Squizzato A; Pellegrinet M; Romano G; Tana M; Mathieu G; Maggioni AP; Fontanella A; Campanini M; Mazzone A; Gussoni G; Dentali F
Eur J Prev Cardiol; 2019 Apr; 26(6):660-663. PubMed ID: 30152250
[No Abstract] [Full Text] [Related]
2. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
3. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
[TBL] [Abstract][Full Text] [Related]
4. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
Wertheimer G; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
[TBL] [Abstract][Full Text] [Related]
6. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
7. Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.
Guelker JE; Bufe A; Klues H; Shin DI; Blockhaus C; Gabriel NH; Haverkamp W; Kroeger K
Cardiovasc Revasc Med; 2019 May; 20(5):399-402. PubMed ID: 30115560
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
9. Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
Chao TF; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Oct; 138(14):1485-1487. PubMed ID: 30354355
[No Abstract] [Full Text] [Related]
10. Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.
Hsu JC; Freeman JV
Clin Pharmacol Ther; 2018 Aug; 104(2):301-310. PubMed ID: 29328506
[TBL] [Abstract][Full Text] [Related]
11. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
[TBL] [Abstract][Full Text] [Related]
12. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.
Asinger RW; Shroff GR; Simegn MA; Herzog CA
Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28893833
[No Abstract] [Full Text] [Related]
14. The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department.
Hua H; Sur N; Choi J; Polineni S; Lee L; Chaturvedi S
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104599. PubMed ID: 32001107
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.
Ermini G; Perrone V; Veronesi C; Degli Esposti L; Di Pasquale G
Vasc Health Risk Manag; 2017; 13():239-246. PubMed ID: 28740396
[TBL] [Abstract][Full Text] [Related]
16. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
17. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
[TBL] [Abstract][Full Text] [Related]
18. Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.
Wehbe RM; Yadlapati A
Tex Heart Inst J; 2016 Aug; 43(4):287-90. PubMed ID: 27547134
[No Abstract] [Full Text] [Related]
19. The use of anticoagulants in the management of atrial fibrillation among general practices in England.
Cowan C; Healicon R; Robson I; Long WR; Barrett J; Fay M; Tyndall K; Gale CP
Heart; 2013 Aug; 99(16):1166-72. PubMed ID: 23393083
[TBL] [Abstract][Full Text] [Related]
20. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
